Pantoprazole NA 20MG Tabs, Delayed Release Pantoprazole NA 40MG Tabs, Delayed Release   3

Background
The solicitation is issued by the Department of Veterans Affairs (VA) under the Pharmaceutical Prime Vendor Program (PPV) to establish a supply source for pharmaceutical products. The purpose is to ensure availability and consistency of products for nationwide usage and to obtain volume-based, committed-use pricing. The contract will be used by VA facilities, Indian Health Service (IHS) facilities, Bureau of Prisons (BOP) facilities, Captain James A. Lovell Federal Health Care Center (FHCC), and State Veteran Homes.

Work Details
The specific products to be provided are Pantoprazole NA 20MG Tablet, Delayed Release, 90 count Bottles (Unit of Use), Pantoprazole NA 40MG Tablet, Delayed Release, 90 count Bottles (Unit of Use), and Pantoprazole NA 40MG Tablet, Delayed Release, 1,000 count Bottles. Offerors must submit prices for the base year and all four one-year options for all line items. The NDC number for each offered drug must be unique to the offeror's company. The packaging requirements include safety-cap capable unit-of-use packaging with specific bottle dimensions and label size.

Period of Performance
The period of performance is not explicitly stated in the provided information.

Place of Performance
The products will be delivered to various VA facilities, IHS facilities, BOP facilities, FHCC, and State Veteran Homes across the United States.